XML 63 R51.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Of Financial Instruments (Fair Value Of Assets And Liabilities Measured On Recurring Basis) (Details) - Recurring [Member] - USD ($)
$ in Thousands
Dec. 31, 2018
Jun. 30, 2018
Dec. 31, 2017
Jun. 30, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Investment in Cell C $ 149,058 $ 172,948    
Cash, cash equivalents and restricted cash (included in other long-term assets) 593      
Cash and cash equivalents (included in other long-term assets)   610    
Fixed maturity investments (included in cash and cash equivalents) 8,319 8,304    
Other 18 18    
Total assets at fair value 157,988 181,880    
DNI contingent consideration 26,790 27,222    
Foreign exchange contracts 95      
Total liabilities at fair value 26,885 27,222    
Quoted Price In Active Markets For Identical Assets (Level 1) [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash, cash equivalents and restricted cash (included in other long-term assets) 593      
Cash and cash equivalents (included in other long-term assets)   610    
Fixed maturity investments (included in cash and cash equivalents) 8,319 8,304    
Total assets at fair value 8,912 8,914    
Significant Other Observable Inputs (Level 2) [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Other 18 18    
Total assets at fair value 18 18    
Foreign exchange contracts 95      
Total liabilities at fair value 95      
Significant Unobservable Inputs (Level 3) [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Investment in Cell C 149,058 172,948    
Total assets at fair value 149,058 172,948 $ 161,695 $ 151,003
DNI contingent consideration 26,790 27,222    
Total liabilities at fair value $ 26,790 $ 27,222